Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

The Role of Adjuvant Treatment in Patients with High-Grade Meningioma

  • Cho, Minjae (Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Joo, Jin-Deok (Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Kim, In Ah (Department of Radiation Oncology, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Han, Jung Ho (Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Oh, Chang Wan (Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Kim, Chae-Yong (Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
  • Received : 2016.11.17
  • Accepted : 2017.04.26
  • Published : 2017.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : To investigate the efficacy of adjuvant treatment in patients with high-grade meningioma. Methods : A retrospective analysis was performed for patients with high-grade meningioma, World Health Organization grade 2 or 3, in a single center between 2003 and 2014. The patients were reviewed according to age at diagnosis, sex, the location of meningioma, degree of tumor resection, histological features, and type of adjuvant treatment. These factors were analyzed by Firth logistic regression analyses. Results : Fifty-three patients with high-grade meningioma were enrolled. Thirty-four patients received adjuvant treatment; conventional radiotherapy or radiosurgery. Clinical follow-up ranged from 13-113 months with a median follow-up of 35.5 months. Gross total removal (GTR), Simpson grade 1 or 2, was achieved in 29 patients and, among them, 13 patients received adjuvant treatment. In the other 24 patients with non-GTR, conventional adjuvant radiotherapy and radiosurgery were performed in 11 and 10 patients, respectively. The other 3 patients did not receive any adjuvant treatment. Radiation-related complications did not occur. Of the 53 patients, 19 patients had suffered from recurrence. The recurrence rate in the adjuvant treatment group was 23.5% (8 out of 34). On the other hand, the rate for the non-adjuvant treatment group was 57.9% (11 out of 19) (odds ratio [OR]=0.208, p=0.017). In the GTR group, the recurrence rate was 7.5% (1 out of 13) for patients with adjuvant treatment and 50% (8 out of 16) for patients without adjuvant treatment (OR=0.121, p=0.04). Conclusion : Adjuvant treatment appears to be safe and effective, and could lead to a lower recurrence rate in high-grade meningioma, regardless of the extent of removal. Our results might be used as a reference for making decisions when planning adjuvant treatments for patients with high-grade meningioma after surgery.

Keywords

References

  1. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, et al. : Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64 : 56-60; discussion 60, 2009 https://doi.org/10.1227/01.NEU.0000330399.55586.63
  2. Dijkstra M, van Nieuwenhuizen D, Stalpers LJ, Wumkes M, Waagemans M, Vandertop WP, et al. : Late neurocognitive sequelae in patients with WHO grade I meningioma. J Neurol Neurosurg Psychiatry 80 : 910-915, 2009 https://doi.org/10.1136/jnnp.2007.138925
  3. Dolecek TA, Propp JM, Stroup NE, Kruchko C : CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 14 Suppl 5 : v1-v49, 2012 https://doi.org/10.1093/neuonc/nos218
  4. Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarides M, Menei P, et al. : WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95 : 367-375, 2009 https://doi.org/10.1007/s11060-009-9934-0
  5. Dziuk TW, Woo S, Butler EB, Thornby J, Grossman R, Dennis WS, et al. : Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol 37 : 177-188, 1998 https://doi.org/10.1023/A:1005853720926
  6. Hardesty DA, Wolf AB, Brachman DG, McBride HL, Youssef E, Nakaji P, et al. : The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection. J Neurosurg 119 : 475-481, 2013 https://doi.org/10.3171/2012.12.JNS12414
  7. Hasan S, Young M, Albert T, Shah AH, Okoye C, Bregy A, et al. : The role of adjuvant radiotherapy after gross total resection of atypical meningiomas. World Neurosurg 83 : 808-815, 2015 https://doi.org/10.1016/j.wneu.2014.12.037
  8. Kaur G, Sayegh ET, Larson A, Bloch O, Madden M, Sun MZ, et al. : Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol 16 : 628-636, 2014 https://doi.org/10.1093/neuonc/nou025
  9. Komotar RJ, Iorgulescu JB, Raper DMS, Holland EC, Beal K, Bilsky MH, et al. : The role of radiotherapy following gross-total resection of atypical meningiomas. J Neurosurg 117 : 679-686, 2012 https://doi.org/10.3171/2012.7.JNS112113
  10. Lawrence YR, Li XA, el Naqa I, Hahn CA, Marks LB, Merchant TE, et al. : Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76(3 Suppl) : S20-S27, 2010 https://doi.org/10.1016/j.ijrobp.2009.02.091
  11. Lee KD, DePowell JJ, Air EL, Dwivedi AK, Kendler A, McPherson CM : Atypical meningiomas: is postoperative radiotherapy indicated? Neurosurg Focus 35 : E15, 2013 https://doi.org/10.3171/2013.9.FOCUS13325
  12. Mair R, Morris K, Scott I, Carroll TA : Radiotherapy for atypical meningiomas. J Neurosurg 115 : 811-819, 2011 https://doi.org/10.3171/2011.5.JNS11112
  13. Palma L, Celli P, Franco C, Cervoni L, Cantore G : Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 86 : 793-800, 1997 https://doi.org/10.3171/jns.1997.86.5.0793
  14. Park HJ, Kang HC, Kim IH, Park SH, Kim DG, Park CK, et al. : The role of adjuvant radiotherapy in atypical meningioma. J Neurooncol 115 : 241-247, 2013 https://doi.org/10.1007/s11060-013-1219-y
  15. Poon MT, Fung LH, Pu JK, Leung GK : Outcome comparison between younger and older patients undergoing intracranial meningioma resections. J Neurooncol 114 : 219-227, 2013 https://doi.org/10.1007/s11060-013-1173-8
  16. Provenzale JM, Ison C, DeLong D : Bidimensional measurements in brain tumors: assessment of interobserver variability. AJR Am J Roentgenol 193 : W515-W522, 2009 https://doi.org/10.2214/AJR.09.2615
  17. Sanai N, Sughrue ME, Shangari G, Chung K, Berger MS, McDermott MW : Risk profile associated with convexity meningioma resection in the modern neurosurgical era. J Neurosurg 112 : 913-919, 2010 https://doi.org/10.3171/2009.6.JNS081490
  18. Saraf S, McCarthy BJ, Villano JL : Update on meningiomas. Oncologist 16 : 1604-1613, 2011 https://doi.org/10.1634/theoncologist.2011-0193
  19. Simpson D : The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20 : 22-39, 1957 https://doi.org/10.1136/jnnp.20.1.22
  20. Stessin AM, Schwartz A, Judanin G, Pannullo SC, Boockvar JA, Schwartz TH, et al. : Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis. J Neurosurg 117 : 669-675, 2012 https://doi.org/10.3171/2012.7.JNS111439
  21. van Nieuwenhuizen D, Klein M, Stalpers LJA, Leenstra S, Heimans JJ, Reijneveld JC : Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients. J Neurooncol 84 : 271-278, 2007 https://doi.org/10.1007/s11060-007-9366-7

Cited by

  1. Current treatment options for meningioma vol.18, pp.3, 2017, https://doi.org/10.1080/14737175.2018.1429920
  2. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma vol.14, pp.1, 2017, https://doi.org/10.1186/s13014-019-1368-z
  3. Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management vol.10, pp.None, 2020, https://doi.org/10.3389/fonc.2020.565582
  4. Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis vol.16, pp.1, 2017, https://doi.org/10.1186/s13014-021-01759-9